Vergis J, McCullumsmith RE. Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line. Translation. 2025;14(S1). doi:10.46570/utjms-2025-1507